Ku, B. M., Choi, M. K., Sun, J., Lee, S., Ahn, J. S., Park, K., & Ahn, M. (2018). Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model. PLoS One.
Citação norma ChicagoKu, Bo Mi, Moon Ki Choi, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, and Myung-Ju Ahn. "Acquired Resistance to AZD9291 As an Upfront Treatment Is Dependent On ERK Signaling in a Preclinical Model." PLoS One 2018.
Citação norma MLAKu, Bo Mi, et al. "Acquired Resistance to AZD9291 As an Upfront Treatment Is Dependent On ERK Signaling in a Preclinical Model." PLoS One 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.